Heart Attack Diagnostic Market Report 2026

Heart Attack Diagnostic Market Overview

• Heart Attack Diagnostic market size has reached to $11.54 billion in 2025 • Expected to grow to $17.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.1% • Growth Driver: Surge In Cardiovascular Disorders Drives Growth In Heart Attack Diagnostics Market • Market Trend: Product Innovation In The Heart Attack Diagnostics Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Heart Attack Diagnostic Market?

Heart attack diagnostics are defined as the methods of identification, monitoring, screening, and prognosis that help validate the heart attack's diagnosis, as well as help, determine the type of heart attack a patient has had, which will help determine the most effective treatment. Heart attack diagnostics are used to diagnose heart disease. The main types of heart attack diagnostic tests are electrocardiogram (ECG/EKG), blood tests, X-ray, echocardiogram, coronary catheterization (angiogram), exercise stress test, and magnetic resonance imaging (MRI) carried out through invasive procedure and non-invasive procedure. An electrocardiogram (ECG) is a quick test that may be performed to examine the electrical activity and rhythm of the heart. The sensors attached to the skin detect the electrical signals produced by the heart each time it beats. The electrocardiogram is used to diagnose and monitor conditions affecting the heart. The heart attack diagnostic is used by hospitals, ambulatory surgical centers, diagnostics centers, and other end-users.

What Is The Heart Attack Diagnostic Market Growth Forecast?

The heart attack diagnostic market size is expected to see strong growth in the next few years. It will grow to $17.9 billion in 2030 at a compound annual growth rate (CAGR) of 9.1%. The growth in the forecast period can be attributed to increasing demand for rapid diagnostic solutions, growing integration of digital health platforms, expansion of remote cardiac monitoring, rising investments in advanced imaging technologies, increasing adoption of precision cardiology diagnostics. Major trends in the forecast period include increasing adoption of ai-assisted diagnostic tools, rising use of high-sensitivity cardiac biomarkers, growing integration of point-of-care testing devices, expansion of non-invasive diagnostic procedures, enhanced focus on rapid emergency diagnostics.

What Is The Driver Of The Heart Attack Diagnostic Market?

The rising prevalence of cardiac disorders is propelling the growth of the heart attack diagnostics market. Cardiac disorders (CVD) are a group of disorders of the heart and blood vessels affecting the heart. Unhealthy eating, inactivity, usage of tobacco products, and abusing alcohol are the main factors for heart disease and stroke. Heart attack diagnosis helps in analyzing the causes and severity of heart attack, stroke, and heart failure. For instance, in January 2024, according to the American Heart Association, a US-based non-profit organization, the age-adjusted death rate from cardiovascular disease increased to 233.3 per 100,000 in 2024 up 4.0% from 224.4 per 100,000 in 2023. Therefore, the rising frequency of cardiovascular illnesses will continue to drive the heart attack diagnostics industry.

Key Players In The Global Heart Attack Diagnostic Market

Major companies operating in the heart attack diagnostic market are Abbott Laboratories, F. Hoffmann-La Roche AG, General Electric Co., Koninklijke Philips NV, Siemens AG, Canon Medical Systems Corporation, GE Healthcare, Roche Diagnostics, Beckman Coulter Inc., Schiller AG, Becton Dickinson and Company, Danaher Corporation, Thermo Fisher Scientific Inc., Quest Diagnostics, Bio-Rad Laboratories Inc., Hitachi Ltd., Toshiba Corp., Fujifilm Holdings, Midmark Corp., Welch Allyn Inc., HILL ROM HOLDINGS Inc., HeartFlow, Cardio Diagnostics Holdings Inc.

Global Heart Attack Diagnostic Market Trends and Insights

Major companies operating in the heart attack diagnostics market are developing innovative products such as coronary heart disease detection tests to meet larger customer bases, more sales, and increase revenue. Coronary heart disease (CHD) detection tests refer to medical assessments and diagnostic procedures designed to identify the presence of coronary heart disease, a condition characterized by the narrowing or blockage of coronary arteries that supply blood to the heart muscle. For instance, in August 2023, Cardio Diagnostics Holdings Inc., a US-based biotechnology company, launched PrecisionCHD. The PrecisionCHD test, a groundbreaking innovation, is a blood-based detection method for coronary heart disease (CHD), setting itself apart as the sole detection technology seamlessly combining epigenetic and genetic biomarkers with Artificial Intelligence (AI). This unique test necessitates only a straightforward blood sample, conveniently collected at a doctor's office or through a simple at-home procedure and employs the same highly scalable laboratory technique utilized in COVID-19 testing. With results available for review within a swift 10 business days, the PrecisionCHD test offers a rapid and efficient alternative to traditional first-line CHD detection tools like stress echocardiograms.

What Are Latest Mergers And Acquisitions In The Heart Attack Diagnostic Market?

In August 2024, Johnson & Johnson, a US-based pharmaceutical industry company, acquired V-Wave Inc. for an undisclosed amount. Through this acquisition, Johnson & Johnson aims to enhance its portfolio, drive innovation, and expand its market reach in the healthcare sector. V-Wave Inc. is a California-based company that primarily focuses on developing innovative medical devices and therapies for heart failure management.

What Defines the Heart Attack Diagnostic Market?

The heart attack diagnostics market includes revenues earned by entities through tests such as stress tests, cardiac catheterization, cardiac computerized tomography (CT) scan, cardiac magnetic resonance imaging (MRI), and angiogram. The market value includes the value of related goods sold by the service provider or included within the service offering. The heart attack diagnostics market also includes sales of wearable ECG devices, cardiac pacemakers, stents, and ventricular assist devices (VADs) which are used in heart attack diagnostics. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Heart Attack Diagnostic Market Report 2026?

The heart attack diagnostic market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the heart attack diagnostic industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.